27-Gauge vitrectomy vs. 25-gauge vitrectomy in the management of proliferative diabetic retinopathy with preoperative intravitreal injection of conbercept

被引:1
|
作者
Xiang, Wu [1 ]
Fang, Dong [2 ]
Jiang, Xintong [1 ]
Zhang, Zhaotian [1 ]
Xiang, Chuqi [1 ]
Huang, Shaofen [1 ]
Zhang, Shaochong [2 ,4 ]
Wei, Yantao [1 ,3 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China
[2] Jinan Univ, Shenzhen Eye Hosp, Shenzhen 518040, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54S Xianlie Rd, Guangzhou 510060, Guangdong, Peoples R China
[4] Jinan Univ, Shenzhen Eye Hosp, 18 Zetian Rd, Shenzhen 518040, Guangdong, Peoples R China
关键词
27-gauge; 25-gauge; vitrectomy; proliferative diabetic retinopathy; conbercept; ENDOTHELIAL GROWTH-FACTOR; CLINICAL-FEATURES; OUTCOMES; BEVACIZUMAB; SURGERY; 20-7-GAUGE; HEMORRHAGE;
D O I
10.3892/etm.2023.12171
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Small-gauge vitrectomy has become popular due to its notable advantages, including less trauma, shortened convalescence and improved manoeuvrability. The aim of the present study was to compare the surgical outcomes of 27-gauge (27-G) vitrectomy with those of 25-gauge (25-G) vitrectomy in the management of proliferative diabetic retinopathy (PDR) with preoperative intravitreal injection of conbercept. The data of 48 consecutive patients with PDR (48 eyes) were retrospectively collected. The patients underwent conbercept intravitreal injection and pars plana vitrectomy with a 27-G group (23 eyes) or 25-G group (25 eyes) vitrectomy system. The operating time, suturing rate, endodiathermy rate, postoperative best-corrected visual acuity (BCVA), intraocular pressure (IOP) and complications were recorded. The mean postoperative BCVA at final follow-up was significantly improved compared with that at the baseline in both groups (P<0.001 for both). The differences in the mean BCVA changes between the two groups were not significant (P>0.99), and no differences were observed in the final central foveal thickness (P=0.51) between the two groups. The final IOP remained stable compared with that at the baseline in the 27-G group (P=0.36) and the 25-G group (P=0.05). The suturing rate was significantly decreased in the 27-G group compared with the 25-G group (P=0.04). There were no significant differences between the two groups in terms of the operating time (P=0.18), rate of endodiathermy use (P>0.99), iatrogenic retinal breaks (P=0.42) or postoperative recurrent vitreous haemorrhage (P>0.99). In addition, no case of ocular hypotony was observed in either group. In conclusion, 27-G vitrectomy was as efficient and safe as 25-G vitrectomy in the management of PDR in terms of operating time and complications. With reference to the literature, preoperative conbercept injection appears to assist in decreasing the incidence of intraoperative and postoperative complications.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Surgical outcomes of 27-gauge and 25-gauge vitrectomy day surgery for proliferative diabetic retinopathy
    Zeon Naruse
    Hiroyuki Shimada
    Ryusaburo Mori
    International Ophthalmology, 2019, 39 : 1973 - 1980
  • [2] Surgical outcomes of 27-gauge and 25-gauge vitrectomy day surgery for proliferative diabetic retinopathy
    Naruse, Zeon
    Shimada, Hiroyuki
    Mori, Ryusaburo
    INTERNATIONAL OPHTHALMOLOGY, 2019, 39 (09) : 1973 - 1980
  • [3] Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy
    Farouk, Mahmoud Mohamed
    Naito, Takeshi
    Sayed, Khulood Mohammed
    Nagasawa, Toshihiko
    Katome, Takashi
    Radwan, Gamal
    Abdallah, Ahmad
    Elagouz, Mohamed
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (03) : 369 - 376
  • [4] Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy
    Mahmoud Mohamed Farouk
    Takeshi Naito
    Khulood Mohammed Sayed
    Toshihiko Nagasawa
    Takashi Katome
    Gamal Radwan
    Ahmad Abdallah
    Mohamed Elagouz
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249 : 369 - 376
  • [5] 25-GAUGE VERSUS 27-GAUGE VITRECTOMY FOR MANAGEMENT OF VITREORETINAL DISEASES
    Benzerroug, Mounir
    Marchand, Maud
    Coisy, Solene
    Briend, Benedicte
    Boussion, Bertrand
    Mazit, Cherif
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (06): : 991 - 996
  • [6] Comparative study of 27-gauge vs 25-gauge vitrectomy for epiretinal membrane
    Mitsui, K.
    Kogo, J.
    Takeda, H.
    Shiono, A.
    Sasaki, H.
    Munemasa, Y.
    Kitaoka, Y.
    Takagi, H.
    EYE, 2016, 30 (04) : 538 - 544
  • [7] Differential distribution of fibrovascular proliferative membranes in 25-gauge vitrectomy for proliferative diabetic retinopathy
    Lu, Nan
    Yang, Shi-Lin
    Guo, Shuo
    Yang, Dong-Ni
    Liu, Li
    Fan, Chun-Hui
    Guo, Ying
    Liu, Jian
    Zhao, Wei
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2024, 17 (08) : 1462 - 1468
  • [8] Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy
    Mao, Jian-Bo
    Wu, Han-Fei
    Chen, Yi-Qi
    Zhao, Shi-Xin
    Tao, Ji-Wei
    Zhang, Yun
    Zheng, Bin
    Wang, Lin
    Shen, Li-Jun
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (07) : 1217 - 1221
  • [9] Outcomes and Complications of 25-Gauge Transconjunctival Sutureless Vitrectomy for Proliferative Diabetic Retinopathy
    Ozone, Daisuke
    Hirano, Yoshio
    Ueda, Jiro
    Yasukawa, Tsutomu
    Yoshida, Munenori
    Ogura, Yuichiro
    OPHTHALMOLOGICA, 2011, 226 (02) : 76 - 80
  • [10] Outcomes of 25-Gauge Pars Plana Vitrectomy in the Surgical Management of Proliferative Diabetic Retinopathy
    Schoenberger, Scott D.
    Miller, Daniel M.
    Riemann, Christopher D.
    Foster, Robert E.
    Sisk, Robert A.
    Hutchins, Robert K.
    Petersen, Michael R.
    OPHTHALMIC SURGERY LASERS & IMAGING, 2011, 42 (06) : 474 - 480